Figure 1.

Local progression-free survival of reirradiated breast cancer patients (months after start of retreatment; n = 29). A heterogeneous group of patients were retreated with operable (R1 or R0 resection) and non-operable recurrent breast tumours with and without distant metastases. Reirradiation was given alone or combined with simultaneous 5-fluoruracil or capecitabine to loco-regional breast cancer recurrences after previous irradiation to the breast, chest wall, and/or regional lymphatic nodes.